Detalhe da pesquisa
1.
Changes in Bone Mass After Discontinuation of Preexposure Prophylaxis With Tenofovir Disoproxil Fumarate/Emtricitabine in Young Men Who Have Sex With Men: Extension Phase Results of Adolescent Trials Network Protocols 110 and 113.
Clin Infect Dis
; 70(4): 687-691, 2020 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31179503
2.
Vitamin D3 Supplementation Increases Spine Bone Mineral Density in Adolescents and Young Adults With Human Immunodeficiency Virus Infection Being Treated With Tenofovir Disoproxil Fumarate: A Randomized, Placebo-Controlled Trial.
Clin Infect Dis
; 66(2): 220-228, 2018 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29020329
3.
Decline in Bone Mass With Tenofovir Disoproxil Fumarate/Emtricitabine Is Associated With Hormonal Changes in the Absence of Renal Impairment When Used by HIV-Uninfected Adolescent Boys and Young Men for HIV Preexposure Prophylaxis.
Clin Infect Dis
; 64(3): 317-325, 2017 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28013265
4.
Low bone mass in behaviorally HIV-infected young men on antiretroviral therapy: Adolescent Trials Network Study 021B.
Clin Infect Dis
; 55(3): 461-8, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22573848
5.
Pharmacokinetics of Emtricitabine/Tenofovir Disoproxil Fumarate Among Transgender Adolescents and Young Adults Without HIV Receiving Gender Affirming Hormones.
AIDS Res Hum Retroviruses
; 38(11): 840-846, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35943868
6.
Gender-Affirming Hormone Pharmacokinetics Among Adolescent and Young Adult Transgender Persons Receiving Daily Emtricitabine/Tenofovir Disoproxil Fumarate.
AIDS Res Hum Retroviruses
; 38(12): 939-943, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35815468
7.
Obesity and dyslipidemia in behaviorally HIV-infected young women: Adolescent Trials Network study 021.
Clin Infect Dis
; 50(1): 106-14, 2010 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19947855
8.
Short Communication: Association of Vitamin D Insufficiency and Protective Tenofovir Diphosphate Concentrations with Bone Toxicity in Adolescent Boys and Young Men Using Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Pre-Exposure Prophylaxis.
AIDS Res Hum Retroviruses
; 35(2): 123-128, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30280906
9.
Safety and Feasibility of Antiretroviral Preexposure Prophylaxis for Adolescent Men Who Have Sex With Men Aged 15 to 17 Years in the United States.
JAMA Pediatr
; 171(11): 1063-1071, 2017 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28873128
10.
Brief Report: Macrophage Activation in HIV-Infected Adolescent Males Contributes to Differential Bone Loss by Sex: Adolescent Trials Network Study 021.
J Acquir Immune Defic Syndr
; 72(4): 372-5, 2016 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26885808
11.
Executive summary--nutritional care of HIV-infected adolescents and adults, including pregnant and lactating women: what do we know, what can we do, and where do we go from here?
Am J Clin Nutr
; 94(6): 1667S-1676S, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22089438